In the past week, EW stock has gone up by 1.75%, with a monthly decline of -1.33% and a quarterly surge of 6.48%. The volatility ratio for the week is 1.59%, and the volatility levels for the last 30 days are 1.92% for Edwards Lifesciences Corp The simple moving average for the past 20 days is 1.26% for EW’s stock, with a 7.59% simple moving average for the past 200 days.
Is It Worth Investing in Edwards Lifesciences Corp (NYSE: EW) Right Now?
The price-to-earnings ratio for Edwards Lifesciences Corp (NYSE: EW) is above average at 51.57x. The 36-month beta value for EW is also noteworthy at 1.11. There are mixed opinions on the stock, with 10 analysts rating it as a “buy,” 5 rating it as “overweight,” 17 rating it as “hold,” and 1 rating it as “sell.”
The public float for EW is 574.69M, and at present, short sellers hold a 1.06% of that float. The average trading volume of EW on July 02, 2025 was 4.58M shares.
EW) stock’s latest price update
Edwards Lifesciences Corp (NYSE: EW) has seen a decline in its stock price by -1.32 in relation to its previous close of 78.21. However, the company has experienced a 1.75% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-06-04 that Edwards Lifesciences is a high-quality, dominant player in structural heart medical devices, with a solid growth history and strong cash generation. The TMTT segment is now the main growth engine, showing rapid expansion, while TAVR growth has plateaued but remains stable. Strategic acquisitions and robust R&D investment position EW for continued innovation and long-term revenue growth above S&P 500 averages.
Analysts’ Opinion of EW
Many brokerage firms have already submitted their reports for EW stocks, with Piper Sandler repeating the rating for EW by listing it as a “Overweight.” The predicted price for EW in the upcoming period, according to Piper Sandler is $80 based on the research report published on April 24, 2025 of the current year 2025.
Stifel, on the other hand, stated in their research note that they expect to see EW reach a price target of $90, previously predicting the price at $75. The rating they have provided for EW stocks is “Buy” according to the report published on January 30th, 2025.
Wolfe Research gave a rating of “Underperform” to EW, setting the target price at $60 in the report published on January 16th of the current year.
EW Trading at 1.88% from the 50-Day Moving Average
After a stumble in the market that brought EW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.97% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EW starting from Wood Larry L, who sale 8,950 shares at the price of $75.23 back on Jun 16 ’25. After this action, Wood Larry L now owns 206,900 shares of Edwards Lifesciences Corp, valued at $673,268 using the latest closing price.
Stock Fundamentals for EW
Current profitability levels for the company are sitting at:
- 0.27 for the present operating margin
- 0.79 for the gross margin
The net margin for Edwards Lifesciences Corp stands at 0.75. The total capital return value is set at 0.13. Equity return is now at value 16.73, with 12.68 for asset returns.
Based on Edwards Lifesciences Corp (EW), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at 0.77.
Currently, EBITDA for the company is 1.72 billion with net debt to EBITDA at -1.32. When we switch over and look at the enterprise to sales, we see a ratio of 7.75. The receivables turnover for the company is 7.61for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.45.
Conclusion
In summary, Edwards Lifesciences Corp (EW) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
